Literature DB >> 7192302

Urinary tract infection caused by Staphylococcus saprophyticus.

P A Jordan, A Iravani, G A Richard, H Baer.   

Abstract

This study was designed to determine whether Staphylococcus saprophyticus was an important cause of urinary tract infection (UTI), as has been reported by European, but not by American, investigators, S. saprophyticus was the second most common cause of UTI in young (mean age, 20 years), sexually active female outpatients without known preexisting kidney disease or preceding manipulation of the urinary tract. Most cases presented as acute cystitis, but frank pyelonephritis and UTI in pregnant females were observed. The organism was rarely found as a contaminant in urine cultures. When present in the mucocutaneous flora of the anal-urogenital area, the organism was significantly associated with UTI by the same organism. These results show that S. saprophyticus should be accepted as an important urinary tract pathogen of young female patients in the United States. A simple adequate laboratory identification may be based on resistance to novobiocin (disk diffusion test), absence of hemolysis and coagulase, and intense pigment production (65% of strains yellow, 35% white).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192302     DOI: 10.1093/infdis/142.4.510

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

Review 1.  Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments.

Authors:  Sana S Dastgheyb; Michael Otto
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

2.  Staphylococcus colonization of the skin and antimicrobial peptides.

Authors:  Michael Otto
Journal:  Expert Rev Dermatol       Date:  2010-04

3.  Slime production by Staphylococcus saprophyticus.

Authors:  E Hjelm; I Lundell-Etherden
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

4.  Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.

Authors:  A Iravani
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.

Authors:  A Iravani; G S Welty; B R Newton; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

6.  Staphylococcus saprophyticus urinary tract infections: epidemiological data from Western Australia.

Authors:  P F Schneider; T V Riley
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

7.  Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.

Authors:  A Iravani; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  Species identification and susceptibility to 17 antibiotics of coagulase-negative staphylococci isolated from clinical specimens.

Authors:  F J Marsik; S Brake
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

9.  Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.

Authors:  A Iravani; G A Richard; H Baer; R Fennell
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

10.  Clinical significance of coagulase-negative staphylococci.

Authors:  C M Sewell; J E Clarridge; E J Young; R K Guthrie
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.